Element has begun shipping AVITI to its first set of customers, comprised of major core labs and genome centers in the US, with some customers purchasing multiple units. “The commitments of these ...

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Genoox, a community-driven genomic data platform, ...

Next-generation sequencing (NGS) has witnessed renewed excitement over the past couple years with several new platforms offering researchers unprecedented accuracy, speed, and flexibility. Launched in ...

Element Biosciences, the developer of the AVITI benchtop sequencer, will be sharing details about its technology and discussing customer stories at the annual meeting of the American Society of Human ...

Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...

Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a partnership with Watchmaker Genomics demonstrating the value and performance of Watchmaker’s DNA ...

NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Gencove, pioneer of low-pass whole genome sequencing and analysis software, and Element Biosciences Inc., developer of the Element AVITI™ System, a new and ...

The Element AVITI Sequencing Platform’s novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuoia Complete Stranded RNA Library Prep Kit and the SEQuoia Express ...

/PRNewswire/ -- Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced it has exceeded 100 ...

SAN DIEGO--(BUSINESS WIRE)-- Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to ...

Venlo, the Netherlands, and San Diego, California, Nov. 02, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic ...

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. SAN DIEGO--(BUSINESS WIRE)-- Element Biosciences, Inc., developer of a new and ...